This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Jun;58(6):737-41.

doi: 10.1136/gut.2008.170530.

Isotretinoin and intestinal inflammation: what gastroenterologists need to know

Matthew Shale¹, Gilaad G Kaplan, Remo Panaccione, Subrata Ghosh

Affiliations

PMID: 19433589
DOI: 10.1136/gut.2008.170530

Review

Isotretinoin and intestinal inflammation: what gastroenterologists need to know

Matthew Shale et al. Gut. 2009 Jun.

. 2009 Jun;58(6):737-41.

doi: 10.1136/gut.2008.170530.

Authors

Matthew Shale¹, Gilaad G Kaplan, Remo Panaccione, Subrata Ghosh

Affiliation

¹ Gastrointestinal Section, Imperial College London, Hammersmith Hospital, London, UK.

PMID: 19433589
DOI: 10.1136/gut.2008.170530

No abstract available

PubMed Disclaimer

Similar articles

[Roaccutane and inflammatory bowel disease].
Pettersson U, Mjorndal T. Pettersson U, et al. Lakartidningen. 2006 Dec 13;103(50-52):4047. Lakartidningen. 2006. PMID: 17330604 Swedish. No abstract available.
Pyoderma gangrenosum associated with isotretinoin therapy.
Freiman A, Brassard A. Freiman A, et al. J Am Acad Dermatol. 2006 Nov;55(5 Suppl):S107-8. doi: 10.1016/j.jaad.2005.09.017. J Am Acad Dermatol. 2006. PMID: 17052521 No abstract available.
Include discussions and review of systems regarding inflammatory bowel disease in patients starting isotretinoin therapy: comment on "Isotretinoin therapy and inflammatory bowel disease".
Mostow EN. Mostow EN. Arch Dermatol. 2011 Jun;147(6):729-30. doi: 10.1001/archdermatol.2011.131. Arch Dermatol. 2011. PMID: 21690538 No abstract available.
Does exposure to isotretinoin increase the risk for the development of inflammatory bowel disease? A meta-analysis.
Lee SY, Jamal MM, Nguyen ET, Bechtold ML, Nguyen DL. Lee SY, et al. Eur J Gastroenterol Hepatol. 2016 Feb;28(2):210-6. doi: 10.1097/MEG.0000000000000496. Eur J Gastroenterol Hepatol. 2016. PMID: 26545085 Review.
Isotretinoin effects on bone.
DiGiovanna JJ. DiGiovanna JJ. J Am Acad Dermatol. 2001 Nov;45(5):S176-82. doi: 10.1067/mjd.2001.113721. J Am Acad Dermatol. 2001. PMID: 11606950 Review.

See all similar articles

Cited by

Lactobacillus plantarum MH-301 as an effective adjuvant to isotretinoin in the treatment of acne vulgaris: a randomized and open-label trail.
Liang L, Qi X, Jiang X, Chen T, Dong L. Liang L, et al. Front Med (Lausanne). 2024 Jan 9;10:1340068. doi: 10.3389/fmed.2023.1340068. eCollection 2023. Front Med (Lausanne). 2024. PMID: 38264057 Free PMC article.
Physiological and Psychological Effects of Isotretinoin in the Treatment of Patients with Acne: A Narrative Review.
Ding RL, Zheng Y, Bu J. Ding RL, et al. Clin Cosmet Investig Dermatol. 2023 Jul 18;16:1843-1854. doi: 10.2147/CCID.S416267. eCollection 2023. Clin Cosmet Investig Dermatol. 2023. PMID: 37483471 Free PMC article. Review.
Isotretinoin-Induced Inflammatory Bowel Disease: Is There a Real Association?
Miqdad MA, Alatta L, Abdelsamad A, Fouda S, Cherukuri ASS, Eltanany M, Albogami F, Al Draiweesh S, Abdelrahman N. Miqdad MA, et al. Cureus. 2022 Oct 2;14(10):e29825. doi: 10.7759/cureus.29825. eCollection 2022 Oct. Cureus. 2022. PMID: 36337815 Free PMC article. Review.
Bacterioboat-A novel tool to increase the half-life period of the orally administered drug.
Kaur P, Ghosh S, Bhowmick A, Gadhave K, Datta S, Ghosh A, Garg N, Mahajan RL, Basu B, Choudhury D. Kaur P, et al. Sci Adv. 2022 Mar 11;8(10):eabh1419. doi: 10.1126/sciadv.abh1419. Epub 2022 Mar 11. Sci Adv. 2022. PMID: 35275724 Free PMC article.
Effect of 60 and 90 days of isotretinoin treatment on the structure of the small intestine mucosa in young male Wistar rats.
Thomazini BF, Dolder MAH. Thomazini BF, et al. Interdiscip Toxicol. 2017 Oct;10(2):45-51. doi: 10.1515/intox-2017-0007. Interdiscip Toxicol. 2017. PMID: 30123036 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.